Literature DB >> 25970491

Faster Heart Rate Recovery With Increased RPE: Paradoxical Responses After an 87-km Ultramarathon.

Theresa N Mann1, Cathrin E Platt, Robert P Lamberts, Michael I Lambert.   

Abstract

The aim of this study was to determine the relationship between heart rate recovery (HRR) and an acute training "overload" by comparing HRR responses before and after an ultramarathon road race. Ten runners completed a standardized laboratory protocol ∼7 days before and between 2 and 4 days after participating in the 87-km Comrades Marathon. The protocol included muscle pain ratings, a 5-bound test, and 20 minutes of treadmill exercise at 70% of maximal oxygen uptake followed by 15 minutes of recovery. Respiratory gases and heart rate measurements were used to calculate steady-state exercise responses, HRR, and excess postexercise oxygen consumption (EPOC), and participants also provided a rating of perceived exertion (RPE) during exercise. The RPE was significantly increased (13 ± 2 vs. 11 ± 1) (p < 0.01), and HRR was significantly faster (35 ± 5 beats vs. 29 ± 4 beats) (p < 0.01) following the postrace vs. prerace submaximal exercise bout, with no significant changes in respiratory or heart rate parameters during exercise or in EPOC. Although previous studies have shown that faster HRR reflected an "adapted" state with enhanced training status, the current findings suggest that this may not always be the case. It follows that changes in HRR should be considered in the context of other factors, such as recent training load and RPE during submaximal exercise.

Entities:  

Mesh:

Year:  2015        PMID: 25970491     DOI: 10.1519/JSC.0000000000001004

Source DB:  PubMed          Journal:  J Strength Cond Res        ISSN: 1064-8011            Impact factor:   3.775


  1 in total

1.  Monitoring training and recovery responses with heart rate measures during standardized warm-up in elite badminton players.

Authors:  Christoph Schneider; Thimo Wiewelhove; Shaun J McLaren; Lucas Röleke; Hannes Käsbauer; Anne Hecksteden; Michael Kellmann; Mark Pfeiffer; Alexander Ferrauti
Journal:  PLoS One       Date:  2020-12-21       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.